XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Noncumulative Preferred Stock
Preferred Stock
Preferred Stock
Noncumulative Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total SVBFG Stockholders’ Equity
Total SVBFG Stockholders’ Equity
Noncumulative Preferred Stock
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2020         51,888,463            
Balance, beginning of period, net of tax at Dec. 31, 2020 $ 8,433   $ 340   $ 0 $ 1,585 $ 5,672 $ 623 $ 8,220   $ 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)         374,039            
Common stock issued under employee benefit plans, net of restricted stock cancellations (1)       $ 0 (1)     (1)    
Issuance of stock (in shares)         4,527,000            
Issuance of stock 2,363 $ 1,724   $ 1,724 $ 0 2,363     2,363 $ 1,724  
Issuance of common stock for the acquisition of Boston Private (in shares)         1,887,981            
Issuance of common stock for the acquisition of Boston Private 1,060         1,060     1,060    
Net income 1,665           1,439   1,439   226
Capital calls and distributions, net (70)                   (70)
Other comprehensive income (loss), net of tax (558)             (558) (558)    
Share-based compensation, net 93         93     93    
Dividends on preferred stock (40)           (40)   (40)    
Balance (in shares) at Sep. 30, 2021         58,677,483            
Balance, end of period, net of tax at Sep. 30, 2021 14,669   2,064   $ 0 5,100 7,071 65 14,300   369
Balance (in shares) at Jun. 30, 2021         54,530,307            
Balance, beginning of period, net of tax at Jun. 30, 2021 11,967   2,064   $ 0 2,755 6,706 142 11,667   300
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)         32,195            
Common stock issued under employee benefit plans, net of restricted stock cancellations 2         2     2    
Issuance of stock (in shares)         2,227,000            
Issuance of stock 1,245       $ 0 1,245     1,245    
Issuance of common stock for the acquisition of Boston Private (in shares)         1,887,981            
Issuance of common stock for the acquisition of Boston Private 1,060       $ 0 1,060     1,060    
Net income 475           387   387   88
Capital calls and distributions, net (19)                   (19)
Other comprehensive income (loss), net of tax (77)             (77) (77)    
Share-based compensation, net 38         38     38    
Dividends on preferred stock (22)           (22)   (22)    
Balance (in shares) at Sep. 30, 2021         58,677,483            
Balance, end of period, net of tax at Sep. 30, 2021 14,669   2,064   $ 0 5,100 7,071 65 14,300   369
Balance (in shares) at Dec. 31, 2021         58,748,469            
Balance, beginning of period, net of tax at Dec. 31, 2021 16,609   3,646   $ 0 5,157 7,442 (9) 16,236   373
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)         355,655            
Common stock issued under employee benefit plans, net of restricted stock cancellations (31)       $ 0 (31)     (31)    
Net income 1,304           1,357   1,357   (53)
Capital calls and distributions, net (19)                   (19)
Other comprehensive income (loss), net of tax (2,076)             (2,076) (2,076)    
Share-based compensation, net 146         146     146    
Dividends on preferred stock (123)           (123)   (123)    
Balance (in shares) at Sep. 30, 2022         59,104,124            
Balance, end of period, net of tax at Sep. 30, 2022 15,810   3,646   $ 0 5,272 8,676 (2,085) 15,509   301
Balance (in shares) at Jun. 30, 2022         59,081,326            
Balance, beginning of period, net of tax at Jun. 30, 2022 16,276   3,646   $ 0 5,223 8,247 (1,198) 15,918   358
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)         22,798            
Common stock issued under employee benefit plans, net of restricted stock cancellations (2)         (2)     (2)    
Net income 418           469   469   (51)
Capital calls and distributions, net (6)                   (6)
Other comprehensive income (loss), net of tax (887)             (887) (887)    
Share-based compensation, net 51         51     51    
Dividends on preferred stock (40)           (40)   (40)    
Balance (in shares) at Sep. 30, 2022         59,104,124            
Balance, end of period, net of tax at Sep. 30, 2022 $ 15,810   $ 3,646   $ 0 $ 5,272 $ 8,676 $ (2,085) $ 15,509   $ 301